Hi Zack, all
OK, now I remember why I always try to stay out of license discussions.. :-)
(FWIW: IMHO there is a big difference between massively multiple-authored WP and single or small-group authored research articles, but whatever.)
To sum up: one license (CC BY-NC-ND 2.0 AU) does not allow commercial use or derivatives (better for authors?), the other (CC BY 4.0) does (better for the Cause?)
What do others think?
cheers
Mathieu
=====================================================
KEY POINTS BELOW:::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::
=====================================================
Angela argues for https://creativecommons.org/licenses/by-nc-nd/2.0/au/
Zack argues for https://creativecommons.org/licenses/by/4.0/
|
elifesciences.org
We believe that open access to research findings and associated data has the potential to revolutionise the scientific enterprise
|
|
www.plos.org
Appropriate attribution can be provided by simply citing the original article (e.g., Huntingtin Interacting Proteins Are Genetic Modifiers of Neurodegeneration.
|
|
peerj.com
PeerJ is an Open Access, peer-reviewed, scholarly journal, whilst PeerJ Preprints is a venue for rapid communication of results.
|